Live Attenuated SARS – CoV-2 Vaccine
/ Indian Immunologicals, Griffith University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 27, 2024
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants.
(PubMed, Nat Commun)
- "We generate an intranasal live-attenuated SARS-CoV-2 vaccine, CDO-7N-1, using codon deoptimization...Antibody responses are sustained and enhanced by repeated immunization or infection with WT SARS-CoV-2. Immunity against all SARS-CoV-2 proteins by CDO-7N-1 should improve efficacy against future SARS-CoV-2 variants."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
September 23, 2022
Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
(PubMed, PLoS Pathog)
- No abstract available
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1